This content is from: China (PRC)

Take local practice into account

Chinese patent practice is very different from that of the EU, US, or Japan. Amy Feng of Liu, Shen & Associates urges firms to consider it when patenting second medical indications In China

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial